Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Immune Pharmaceuticals Inc

+ Add to Watchlist

IMNP:US

1.8000 USD 0.1200 6.25%

As of 13:49:25 ET on 03/31/2015.

Snapshot for Immune Pharmaceuticals Inc (IMNP)

Open: 2.0500 Day's Range: 1.7500 - 2.0500 Volume: 82,929
Previous Close: 1.9200 52wk Range: 1.5000 - 5.2100 1-Yr Rtn: -62.66%

Stock Chart for IMNP

No chart data available.
  • IMNP:US 1.7980
  • 1D
  • 1M
  • 1Y
1.9200
Interactive IMNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMNP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -1.6856
Est. EPS (CAD) (12/2014) -1.5260
Est. PEG Ratio -
Market Cap (M USD) 42.53
Shares Outstanding (M) 22.50
30 Day Average Volume 203,609
Price/Book (mrq) 3.6670
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMNP

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for IMNP

Immune Pharmaceuticals Inc. is a biopharmaceutical company. The Company focuses on the development of antibody therapeutics to address medical needs in the treatment of inflammatory diseases and cancer.

Daniel Geodeon TeperCEO/FounderGad BerdugoExec VP/CFO
Paul I NadlerActing Exec VP:Rsch & Dev/Chief Medical OfcrOshrat FerenkelVP:Nano therapeutics R&D
More Company Profile & Key Executives for IMNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil